- Author:
- Hanne <Hanne@hanne-nielsens-macbook.local>
- Date:
- 2010-01-13 14:48:41+13:00
- Desc:
- Added cmeta:ids to CellML file and added session file
- Permanent Source URI:
- https://models.physiomeproject.org/workspace/kirschner_panetta_1998/rawfile/f26cd932a3d8950088878dea3d3201495209d959/kirschner_panetta_1998.cellml
<?xml version="1.0"?>
<!-- FILE : kirschner_model_1998.xml
CREATED : 28th March 2004
LAST MODIFIED : 28th March 2004
AUTHOR : Catherine Lloyd
Bioengineering Institute
The University of Auckland
MODEL STATUS : This model conforms to the CellML 1.0 Specification released on
10th August 2001, and the 16/1/02 CellML Metadata 1.0 Specification.
DESCRIPTION : This file contains a CellML description of Kirschner and Panetta's 1998 mathematical model of the immunotherapy of the tumour-immune interaction.
CHANGES:
--><model xmlns="http://www.cellml.org/cellml/1.0#" xmlns:cmeta="http://www.cellml.org/metadata/1.0#" xml:base="file:///Users/Hanne/Desktop/repository%20models/kirschner_panetta_1998/kirschner_panetta_1998.cellml" cmeta:id="kirschner_panetta_1998_version01" name="kirschner_panetta_1998_version01">
<documentation xmlns="http://cellml.org/tmp-documentation">
<article>
<articleinfo>
<title>Modelling Immunotherapy of the Tumour-Immune Interaction</title>
<author>
<firstname>Catherine</firstname>
<surname>Lloyd</surname>
<affiliation>
<shortaffil>Bioengineering Institute, University of Auckland</shortaffil>
</affiliation>
</author>
</articleinfo>
<section id="sec_status">
<title>Model Status</title>
<para>
This model has been recoded using the nondimensionalized equations. This was suggested by the author to help with solving the problem, due to its very stiff nature. Some but not all output from the paper can be reproduced by this model. Values of s1 and s2 have been set to zero to represent a non-treatment situation. A value of 0.025 has been given to the variable c, which defines the antigenicity of the tumour, to represent the middle of the range given for this parameter. The model may be re-parameterised to give other relevant outputs, for example, if s1 is greater than 0 while s2 equals 0, the model can simulate adoptive cellular immunotherapy.
This version is known to run in PCEnv and COR, and passes all unit checks (being non-dimensionalized).
</para>
</section>
<sect1 id="sec_structure">
<title>Model Structure</title>
<para>
Cancer is one of the leading causes of death in the world, yet little is understood about the mechanisms which underlie its establishment and destruction. While surgery and/or chemo- and radiotherapy are an important part of treating cancer, they do not represent an 100% effective cure, and often patients will experience a relapse. There is a great motivation to find preventative measures and more effective treatment strategies for cancer, and efforts are being channeled into immunotherapy. Immunotherapy refers to the use of cytokines in the treatment of cancer.
</para>
<para>
Cytokines are protein hormones that mediate both natural and specific immunity. They are mainly produced by activated T lymphocytes during cellular mediated immune responses. Interleukin-2 (IL-2) is the main cytokine responsible for lymphocyte activation, growth, and differnetiation. It is produced by CD4<superscript>+</superscript> (or helper) T cells and to a lesser extent, by CD8<superscript>+</superscript> (or cytotoxic) T cells. Because IL-2 acts on the same cells that produce it, it is referred to as an autocrine growth factor, although it can also act on nearby T cells, making it a paracrine growth factor. In clinical trials, IL-2 has been shown to enhance CD8<superscript>+</superscript> T cell activity at different disease stages. Also, natural killer (NK) cell activity is restored and CD4<superscript>+</superscript> and CD8<superscript>+</superscript> T cell populations expand.
</para>
<para>
Adoptive cellular immunotherapy (ACI) refers to the injection of cultured immune cells that have anti-tumour activity into a patient with a tumour. Large amounts of IL-2 are also introduced in one of two ways:
</para>
<itemizedlist>
<listitem>
<para>1) <emphasis>LAK-(lymphocyte-activated killer cell) therapy</emphasis> - These cells are derived from <emphasis>in vitro</emphasis> culturing with high concentrations of IL-2 of peripheral blood leukocytes removed from patients with tumours. The LAKs are then injected back into the patient at the cancer site. These cells are mainly thaought to be NK cells.</para>
</listitem>
<listitem>
<para>2) <emphasis>TIL-(tumour infiltrating lymphocyte) therapy</emphasis> - These cells are derived from lymphocytes recovered from the patient's tumours. They are then incubated with high concentrations of IL-2 <emphasis>in vitro</emphasis> and are comprised of activated NK cells and CD8<superscript>+</superscript> T cells. They are then injected back into the patient at the tumour site.</para>
</listitem>
</itemizedlist>
<para>
Kirschner and Panetta use ideas from pre-existing mathematical models of tumour-immune dymanics and combine them in the simple model shown in <xref linkend="fig_reaction_diagram"/> below. They define three populations:
</para>
<itemizedlist>
<listitem>
<para>1) the activated immune system cells, which include CD8<superscript>+</superscript> T cells, macrophages and NK cells, and are called effector cells;</para>
</listitem>
<listitem>
<para>2) the tumour cells; and</para>
</listitem>
<listitem>
<para>3) the concentration of IL-2.</para>
</listitem>
</itemizedlist>
<para>
The mathematical model describes the interactions between the effector cells, tumour cells and the cytokine IL-2.
</para>
<para>
The model has been described here in CellML (the raw CellML description of the Kirscher and Panetta 1998 model can be downloaded in various formats as described in <xref linkend="sec_download_this_model"/>).
</para>
<para>
The complete original paper reference is cited below:
</para>
<para>
Modeling immunotherapy of the tumor - immune interaction, Denise Kirschner and John Carl Panetta, 1998,
<emphasis>Journal of Mathematical Biology</emphasis>, 37, 235-252. <ulink url="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9785481&dopt=Abstract">PubMed ID: 9785481</ulink>
</para>
<informalfigure float="0" id="fig_reaction_diagram">
<mediaobject>
<imageobject>
<objectinfo>
<title>reaction diagram</title>
</objectinfo>
<imagedata fileref="kirschner_1998.png"/>
</imageobject>
<caption>
A schematic diagram of the interactions between the effector T cells, the tumour cells, and the cytokine interleukin-2 (IL-2).
</caption>
</mediaobject>
</informalfigure>
</sect1>
</article>
</documentation>
<units name="day">
<unit multiplier="86400.0" units="second"/>
</units>
<units name="first_order_rate_constant">
<unit exponent="-1" units="day"/>
</units>
<units base_units="yes" name="cells"/>
<units name="cells_per_microlitre">
<unit units="cells"/>
<unit exponent="-1" prefix="micro" units="litre"/>
</units>
<units name="flux">
<unit units="cells"/>
<unit exponent="-1" prefix="micro" units="litre"/>
<unit exponent="-1" units="day"/>
</units>
<units name="micromolar">
<unit prefix="micro" units="mole"/>
<unit exponent="-1" units="litre"/>
</units>
<component name="environment">
<variable cmeta:id="environment_tau" name="tau" public_interface="out" units="dimensionless"/>
</component>
<component cmeta:id="x" name="x">
<variable initial_value="0.03" name="mu2" units="dimensionless"/>
<variable initial_value="0.025" name="c" units="dimensionless"/>
<variable initial_value="0.1245" name="p1" units="dimensionless"/>
<variable initial_value="2.0E-7" name="g1" units="dimensionless"/>
<variable cmeta:id="x_s1" initial_value="0" name="s1" units="dimensionless"/>
<variable name="tau" public_interface="in" units="dimensionless"/>
<math xmlns="http://www.w3.org/1998/Math/MathML" id="d(x)/d(tau)">
<apply>
<eq/>
<apply>
<diff/>
<bvar>
<ci>tau</ci>
</bvar>
<ci>x</ci>
</apply>
<apply>
<plus/>
<apply>
<minus/>
<apply>
<times/>
<ci>c</ci>
<ci>y</ci>
</apply>
<apply>
<times/>
<ci>mu2</ci>
<ci>x</ci>
</apply>
</apply>
<apply>
<divide/>
<apply>
<times/>
<ci>p1</ci>
<ci>x</ci>
<ci>z</ci>
</apply>
<apply>
<plus/>
<ci>g1</ci>
<ci>z</ci>
</apply>
</apply>
<ci>s1</ci>
</apply>
</apply>
</math>
<variable initial_value="" name="y" public_interface="in" units="dimensionless"/>
<variable cmeta:id="x_x" initial_value="" name="x" public_interface="out" units="dimensionless"/>
<variable name="z" public_interface="in" units="dimensionless"/>
</component>
<component cmeta:id="y" name="y">
<variable cmeta:id="y_y" initial_value="1" name="y" public_interface="out" units="dimensionless"/>
<variable initial_value="0.18" name="r2" units="dimensionless"/>
<variable initial_value="1.0" name="a" units="dimensionless"/>
<variable initial_value="1.0E-9" name="b" units="dimensionless"/>
<variable initial_value="1.0E5" name="g2" units="dimensionless"/>
<variable name="x" public_interface="in" units="dimensionless"/>
<variable name="tau" public_interface="in" units="dimensionless"/>
<math xmlns="http://www.w3.org/1998/Math/MathML" id="d(y)/d(tau )">
<apply>
<eq/>
<apply>
<diff/>
<bvar>
<ci>tau</ci>
</bvar>
<ci>y</ci>
</apply>
<apply>
<minus/>
<apply>
<times/>
<ci>r2</ci>
<ci>y</ci>
<apply>
<minus/>
<cn xmlns:cellml="http://www.cellml.org/cellml/1.0#" cellml:units="dimensionless">1</cn>
<apply>
<times/>
<ci>b</ci>
<ci>y</ci>
</apply>
</apply>
</apply>
<apply>
<divide/>
<apply>
<times/>
<ci>a</ci>
<ci>x</ci>
<ci>y</ci>
</apply>
<apply>
<plus/>
<ci>g2</ci>
<ci>y</ci>
</apply>
</apply>
</apply>
</apply>
</math>
</component>
<component cmeta:id="z" name="z">
<variable cmeta:id="z_z" initial_value="" name="z" public_interface="out" units="dimensionless"/>
<variable initial_value="10.0" name="mu3" units="dimensionless"/>
<variable initial_value="5.0" name="p2" units="dimensionless"/>
<variable initial_value="1.0E3" name="g3" units="dimensionless"/>
<variable cmeta:id="z_s2" initial_value="0" name="s2" units="dimensionless"/>
<variable name="x" public_interface="in" units="dimensionless"/>
<variable name="y" public_interface="in" units="dimensionless"/>
<variable name="tau" public_interface="in" units="dimensionless"/>
<math xmlns="http://www.w3.org/1998/Math/MathML" id="d(z)/d(tau)">
<apply>
<eq/>
<apply>
<diff/>
<bvar>
<ci>tau</ci>
</bvar>
<ci>z</ci>
</apply>
<apply>
<plus/>
<apply>
<minus/>
<apply>
<divide/>
<apply>
<times/>
<ci>p2</ci>
<ci>x</ci>
<ci>y</ci>
</apply>
<apply>
<plus/>
<ci>g3</ci>
<ci>y</ci>
</apply>
</apply>
<apply>
<times/>
<ci>mu3</ci>
<ci>z</ci>
</apply>
</apply>
<ci>s2</ci>
</apply>
</apply>
</math>
</component>
<connection>
<map_components component_1="x" component_2="environment"/>
<map_variables variable_1="tau" variable_2="tau"/>
</connection>
<connection>
<map_components component_1="y" component_2="environment"/>
<map_variables variable_1="tau" variable_2="tau"/>
</connection>
<connection>
<map_components component_1="z" component_2="environment"/>
<map_variables variable_1="tau" variable_2="tau"/>
</connection>
<connection>
<map_components component_1="x" component_2="y"/>
<map_variables variable_1="y" variable_2="y"/>
<map_variables variable_1="x" variable_2="x"/>
</connection>
<connection>
<map_components component_1="x" component_2="z"/>
<map_variables variable_1="z" variable_2="z"/>
<map_variables variable_1="x" variable_2="x"/>
</connection>
<connection>
<map_components component_1="z" component_2="y"/>
<map_variables variable_1="y" variable_2="y"/>
</connection>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"><rdf:Description rdf:about=""><cmeta:comment><rdf:Description rdf:about="rdf:#d0a4817b-aeb5-491c-9484-3091f76cd007"/></cmeta:comment><publisher xmlns="http://purl.org/dc/elements/1.1/" xml:lang="en">The University of Auckland, Bioengineering Institute</publisher><cmeta:modification><rdf:Description rdf:about="rdf:#a24cbc57-027d-4fba-95f1-1563ba0d8fc1"/></cmeta:modification><cmeta:modification><rdf:Description rdf:about="rdf:#9bf3649e-8cc7-4f8b-b5ea-cc542019938a"/></cmeta:modification><creator xmlns="http://purl.org/dc/elements/1.1/"><rdf:Description rdf:about="rdf:#aa2df9c4-c17a-498e-ba4f-f2c88bb16e2b"/></creator><created xmlns="http://purl.org/dc/terms/"><rdf:Description rdf:about="rdf:#c1bcdb0d-b7e3-4c3f-bf0d-5354eac56da1"/></created></rdf:Description><rdf:Description rdf:about="rdf:#3831f29c-be0d-437a-97b8-146d424193b4"><FN xmlns="http://www.w3.org/2001/vcard-rdf/3.0#" xml:lang="en">Catherine Lloyd</FN></rdf:Description><rdf:Description rdf:about="rdf:#$n+h6c"><endingValue xmlns="http://www.cellml.org/metadata/simulation/1.0#" xml:lang="en">400</endingValue><releps xmlns="http://www.cellml.org/metadata/simulation/1.0#nonstandard-" xml:lang="en">1e-6</releps><algorithm xmlns="http://www.cellml.org/metadata/simulation/1.0#nonstandard-" xml:lang="en">bdf15</algorithm><maximumStepSize xmlns="http://www.cellml.org/metadata/simulation/1.0#" xml:lang="en">0.01</maximumStepSize><abseps xmlns="http://www.cellml.org/metadata/simulation/1.0#nonstandard-" xml:lang="en">1e-6</abseps><pointDensity xmlns="http://www.cellml.org/metadata/simulation/1.0#nonstandard-" xml:lang="en">1000000</pointDensity></rdf:Description><rdf:Description rdf:about="rdf:#c3d38c25-413b-4dfc-827a-3999dcce4143"><rdf:value><rdf:Description rdf:about="rdf:#a6341a62-d49f-4c5e-b052-b471cda300fe"/></rdf:value><subject_type xmlns="http://www.cellml.org/bqs/1.0#" xml:lang="en">keyword</subject_type></rdf:Description><rdf:Description rdf:about="rdf:#3649cadb-1733-41d3-babc-4cb88ab82afd"><subject xmlns="http://purl.org/dc/elements/1.1/"><rdf:Description rdf:about="rdf:#c3d38c25-413b-4dfc-827a-3999dcce4143"/></subject></rdf:Description><rdf:Description rdf:about="rdf:#aab9ea91-efce-4b60-b249-f52a1dfd9b37"><Other xmlns="http://www.w3.org/2001/vcard-rdf/3.0#" xml:lang="en">May</Other><Given xmlns="http://www.w3.org/2001/vcard-rdf/3.0#" xml:lang="en">Catherine</Given><Family xmlns="http://www.w3.org/2001/vcard-rdf/3.0#" xml:lang="en">Lloyd</Family></rdf:Description><rdf:Description rdf:about="z"><alternative xmlns="http://purl.org/dc/terms/" xml:lang="en">non-dimensionalized form of variable IL - concentration of the cytokine IL-2 in the single tumour-site compartment</alternative><title xmlns="http://purl.org/dc/elements/1.1/" xml:lang="en">z</title></rdf:Description><rdf:Description rdf:about="rdf:#e154f7c9-084c-4a76-9f36-3b09016588cb"><Orgname xmlns="http://www.w3.org/2001/vcard-rdf/3.0#" xml:lang="en">The University of Auckland</Orgname><Orgunit xmlns="http://www.w3.org/2001/vcard-rdf/3.0#" xml:lang="en">The Bioengineering Institute</Orgunit></rdf:Description><rdf:Description rdf:about="rdf:#099ad25d-111d-475d-9e17-54d7846d5f5a"><N xmlns="http://www.w3.org/2001/vcard-rdf/3.0#"><rdf:Description rdf:about="rdf:#ee35e1db-6e21-4c20-9a7c-e9d2929721b7"/></N></rdf:Description><rdf:Description rdf:about="rdf:#88f4a598-80a7-45d2-b1b1-3b058e01e91a"><N xmlns="http://www.w3.org/2001/vcard-rdf/3.0#"><rdf:Description rdf:about="rdf:#57743721-d471-4520-8b80-77dec871ac34"/></N></rdf:Description><rdf:Description rdf:about="rdf:#$m+h6c"><rdf:rest><rdf:Description rdf:about="http://www.w3.org/1999/02/22-rdf-syntax-ns#nil"/></rdf:rest><rdf:first><rdf:Description rdf:about="rdf:#$n+h6c"/></rdf:first></rdf:Description><rdf:Description rdf:about="rdf:#aa603c82-784d-4e82-8640-486a45092616"><W3CDTF xmlns="http://purl.org/dc/terms/" xml:lang="en">2007-08-06T10:50:28+12:00</W3CDTF></rdf:Description><rdf:Description rdf:about="rdf:#c1bcdb0d-b7e3-4c3f-bf0d-5354eac56da1"><W3CDTF xmlns="http://purl.org/dc/terms/" xml:lang="en">2004-03-28T00:00:00+00:00</W3CDTF></rdf:Description><rdf:Description rdf:about="rdf:#ec750012-9407-451c-b78a-a6100474e6f7"><W3CDTF xmlns="http://purl.org/dc/terms/" xml:lang="en">1998-09</W3CDTF></rdf:Description><rdf:Description rdf:about="rdf:#9bf3649e-8cc7-4f8b-b5ea-cc542019938a"><cmeta:modifier><rdf:Description rdf:about="rdf:#88f4a598-80a7-45d2-b1b1-3b058e01e91a"/></cmeta:modifier><rdf:value xml:lang="en">Values of 1.0 and 0.1 have been used for the variables s1 and s2, respectively, which allows this model to run. s1 is a treatment term that represents an external source of effector cells such as LAK or TIL cells. s2 is a treatment term that represents an input of IL2 into the system. The values for these variables are not given in the paper but those given here appear to be reasonable.</rdf:value><modified xmlns="http://purl.org/dc/terms/"><rdf:Description rdf:about="rdf:#7c6a9638-372d-4191-b362-847260b56871"/></modified></rdf:Description><rdf:Description rdf:about="rdf:#57743721-d471-4520-8b80-77dec871ac34"><Other xmlns="http://www.w3.org/2001/vcard-rdf/3.0#" xml:lang="en">Richard</Other><Given xmlns="http://www.w3.org/2001/vcard-rdf/3.0#" xml:lang="en">James</Given><Family xmlns="http://www.w3.org/2001/vcard-rdf/3.0#" xml:lang="en">Lawson</Family></rdf:Description><rdf:Description rdf:about="rdf:#5192b9e4-77d0-4709-b492-31dab6084014"><Journal xmlns="http://www.cellml.org/bqs/1.0#"><rdf:Description rdf:about="rdf:#d5895ccf-7b31-433b-adaf-969aa226549a"/></Journal><creator xmlns="http://purl.org/dc/elements/1.1/"><rdf:Description rdf:about="rdf:#b3e2cb6a-293f-4847-8a12-d7c5443f4efc"/></creator><title xmlns="http://purl.org/dc/elements/1.1/" xml:lang="en">Modeling immunotherapy of the tumor-immune interaction</title><first_page xmlns="http://www.cellml.org/bqs/1.0#" xml:lang="en">235</first_page><volume xmlns="http://www.cellml.org/bqs/1.0#" xml:lang="en">37</volume><last_page xmlns="http://www.cellml.org/bqs/1.0#" xml:lang="en">252</last_page><issued xmlns="http://purl.org/dc/terms/"><rdf:Description rdf:about="rdf:#ec750012-9407-451c-b78a-a6100474e6f7"/></issued></rdf:Description><rdf:Description rdf:about="rdf:#a24cbc57-027d-4fba-95f1-1563ba0d8fc1"><cmeta:modifier><rdf:Description rdf:about="rdf:#099ad25d-111d-475d-9e17-54d7846d5f5a"/></cmeta:modifier><rdf:value xml:lang="en">Rewrote the model to use the non-dimensionalised equations (given in the paper.) Non-dimensionalized all variables so model will now meet unit tests. Author suggested that NDization helps with solving the model, which is very stiff.</rdf:value><modified xmlns="http://purl.org/dc/terms/"><rdf:Description rdf:about="rdf:#aa603c82-784d-4e82-8640-486a45092616"/></modified></rdf:Description><rdf:Description rdf:about="x"><alternative xmlns="http://purl.org/dc/terms/" xml:lang="en">non-dimensionalized form of T - effector T cells</alternative><title xmlns="http://purl.org/dc/elements/1.1/" xml:lang="en">x</title></rdf:Description><rdf:Description rdf:about="rdf:#ee35e1db-6e21-4c20-9a7c-e9d2929721b7"><Other xmlns="http://www.w3.org/2001/vcard-rdf/3.0#" xml:lang="en">Richard</Other><Given xmlns="http://www.w3.org/2001/vcard-rdf/3.0#" xml:lang="en">James</Given><Family xmlns="http://www.w3.org/2001/vcard-rdf/3.0#" xml:lang="en">Lawson</Family></rdf:Description><rdf:Description rdf:about="rdf:#8682124e-fef8-42e5-940c-d24295a30e39"><Given xmlns="http://www.w3.org/2001/vcard-rdf/3.0#" xml:lang="en">Denise</Given><Family xmlns="http://www.w3.org/2001/vcard-rdf/3.0#" xml:lang="en">Kirschner</Family></rdf:Description><rdf:Description rdf:about="rdf:#e0fcad6f-4780-45b3-a73d-e4b73dbcb28b"><Pubmed_id xmlns="http://www.cellml.org/bqs/1.0#" xml:lang="en">9785481</Pubmed_id><JournalArticle xmlns="http://www.cellml.org/bqs/1.0#"><rdf:Description rdf:about="rdf:#5192b9e4-77d0-4709-b492-31dab6084014"/></JournalArticle></rdf:Description><rdf:Description rdf:about="rdf:#d0a4817b-aeb5-491c-9484-3091f76cd007"><rdf:value xml:lang="en">This model has been recoded using the nondimensionalised equations. This was suggested by the author to help with solving the problem, due to its very stiff nature. Some but not all output from the paper can be reproduced by this model. Values of s1 and s2 have been set to zero to represent a non-treatment situation. A value of 0.025 has been given to the variable c, which defines the antigenicity of the tumour, to represent the middle of the range given for this parameter. The model may be re-parameterised to give other relevant outputs, for example, if s1 is greater than 0 while s2 equals 0, the model can simulate adoptive cellular immunotherapy.
This version is known to run in PCEnv and is likely to run in COR, and passes all unit checks (being non-dimensionalised). This version is able to produce some of the figures in the paper. Contact with the model author re: some parameters is pending.</rdf:value><creator xmlns="http://purl.org/dc/elements/1.1/"><rdf:Description rdf:about="rdf:#1d98e31d-114d-4c82-8628-070b4de48817"/></creator></rdf:Description><rdf:Description rdf:about="rdf:#0fd04615-e14d-4441-854c-9420d4e6d420"><rdf:value xml:lang="en">This is the CellML description of Kirschner and Panetta's 1998 mathematical model of the immunotherapy of the tumour-immune interaction.</rdf:value><creator xmlns="http://purl.org/dc/elements/1.1/"><rdf:Description rdf:about="rdf:#3831f29c-be0d-437a-97b8-146d424193b4"/></creator></rdf:Description><rdf:Description rdf:about="rdf:#a6341a62-d49f-4c5e-b052-b471cda300fe"><rdf:_7 xml:lang="en">cytokine</rdf:_7><rdf:_1 xml:lang="en">tumour</rdf:_1><rdf:_2 xml:lang="en">immunology</rdf:_2><rdf:_6 xml:lang="en">T cell</rdf:_6><rdf:type><rdf:Description rdf:about="http://www.w3.org/1999/02/22-rdf-syntax-ns#Bag"/></rdf:type><rdf:_3 xml:lang="en">pharmacology</rdf:_3><rdf:_5 xml:lang="en">t cell</rdf:_5><rdf:_4 xml:lang="en">signal transduction</rdf:_4></rdf:Description><rdf:Description rdf:about="rdf:#aa2df9c4-c17a-498e-ba4f-f2c88bb16e2b"><N xmlns="http://www.w3.org/2001/vcard-rdf/3.0#"><rdf:Description rdf:about="rdf:#aab9ea91-efce-4b60-b249-f52a1dfd9b37"/></N><EMAIL xmlns="http://www.w3.org/2001/vcard-rdf/3.0#"><rdf:Description rdf:about="rdf:#96eb2588-5f64-404f-9f59-a8c820ece1f9"/></EMAIL><ORG xmlns="http://www.w3.org/2001/vcard-rdf/3.0#"><rdf:Description rdf:about="rdf:#e154f7c9-084c-4a76-9f36-3b09016588cb"/></ORG></rdf:Description><rdf:Description rdf:about="#kirschner_panetta_1998_version01"><simulation xmlns="http://www.cellml.org/metadata/simulation/1.0#"><rdf:Description rdf:about="rdf:#$l+h6c"/></simulation><cmeta:comment><rdf:Description rdf:about="rdf:#0fd04615-e14d-4441-854c-9420d4e6d420"/></cmeta:comment><cmeta:bio_entity xml:lang="en">T lymphocyte</cmeta:bio_entity><title xmlns="http://purl.org/dc/elements/1.1/" xml:lang="en">Kirschner and Panetta's 1998 mathematical model of the immunotherapy of the tumour-immune interaction.</title><reference xmlns="http://www.cellml.org/bqs/1.0#"><rdf:Description rdf:about="rdf:#e0fcad6f-4780-45b3-a73d-e4b73dbcb28b"/></reference><reference xmlns="http://www.cellml.org/bqs/1.0#"><rdf:Description rdf:about="rdf:#3649cadb-1733-41d3-babc-4cb88ab82afd"/></reference></rdf:Description><rdf:Description rdf:about="rdf:#494c01d2-f107-40e8-9dfe-f83a72d89410"><Other xmlns="http://www.w3.org/2001/vcard-rdf/3.0#" xml:lang="en">Carl</Other><Given xmlns="http://www.w3.org/2001/vcard-rdf/3.0#" xml:lang="en">John</Given><Family xmlns="http://www.w3.org/2001/vcard-rdf/3.0#" xml:lang="en">Panetta</Family></rdf:Description><rdf:Description rdf:about="rdf:#a93f969b-64c7-41e8-8894-9898349f32b2"><N xmlns="http://www.w3.org/2001/vcard-rdf/3.0#"><rdf:Description rdf:about="rdf:#494c01d2-f107-40e8-9dfe-f83a72d89410"/></N><rdf:type><rdf:Description rdf:about="http://www.cellml.org/bqs/1.0#Person"/></rdf:type></rdf:Description><rdf:Description rdf:about="rdf:#d5895ccf-7b31-433b-adaf-969aa226549a"><title xmlns="http://purl.org/dc/elements/1.1/" xml:lang="en">Journal of Mathematical Biology</title></rdf:Description><rdf:Description rdf:about="rdf:#$l+h6c"><boundIntervals xmlns="http://www.cellml.org/metadata/simulation/1.0#"><rdf:Description rdf:about="rdf:#$m+h6c"/></boundIntervals></rdf:Description><rdf:Description rdf:about="rdf:#7c6a9638-372d-4191-b362-847260b56871"><W3CDTF xmlns="http://purl.org/dc/terms/" xml:lang="en">2007-08-02T14:17:42+12:00</W3CDTF></rdf:Description><rdf:Description rdf:about="rdf:#8d323650-f5e6-4ccc-a38f-58505d923318"><N xmlns="http://www.w3.org/2001/vcard-rdf/3.0#"><rdf:Description rdf:about="rdf:#8682124e-fef8-42e5-940c-d24295a30e39"/></N><rdf:type><rdf:Description rdf:about="http://www.cellml.org/bqs/1.0#Person"/></rdf:type></rdf:Description><rdf:Description rdf:about="y"><alternative xmlns="http://purl.org/dc/terms/" xml:lang="en">non-dimensionalized form of variable T - tumour cells</alternative><title xmlns="http://purl.org/dc/elements/1.1/" xml:lang="en">y</title></rdf:Description><rdf:Description rdf:about="rdf:#1d98e31d-114d-4c82-8628-070b4de48817"><FN xmlns="http://www.w3.org/2001/vcard-rdf/3.0#" xml:lang="en">James Lawson</FN></rdf:Description><rdf:Description rdf:about="rdf:#96eb2588-5f64-404f-9f59-a8c820ece1f9"><rdf:value xml:lang="en">c.lloyd@auckland.ac.nz</rdf:value><rdf:type><rdf:Description rdf:about="http://imc.org/vCard/3.0#internet"/></rdf:type></rdf:Description><rdf:Description rdf:about="rdf:#b3e2cb6a-293f-4847-8a12-d7c5443f4efc"><rdf:_1><rdf:Description rdf:about="rdf:#8d323650-f5e6-4ccc-a38f-58505d923318"/></rdf:_1><rdf:_2><rdf:Description rdf:about="rdf:#a93f969b-64c7-41e8-8894-9898349f32b2"/></rdf:_2><rdf:type><rdf:Description rdf:about="http://www.w3.org/1999/02/22-rdf-syntax-ns#Seq"/></rdf:type></rdf:Description></rdf:RDF></model>
